Drug packaging – the main diversities between Europe and America to consider

By | 9 July 2021
Packaging must meet a list of objectives, such as: conserve the goods, avoid theft, be cheap, and maintain an equilibrium between its efficacy and its cost, both from the standpoint of the material employed and the time occupied to develop the packing.

From an environmental perspective, it is vital that materials are quickly recycled and employed as small as possible.
Exist numerous goods on the market that may be mistaken between each other by cause of identical shapes, colors or logos. Drug packaging should differ significantly from hygiene and cooking products. For instance, US tablet packaging confuses a drug with a food, and that is not a good idea… for the purchaser. Packaging for human drugs is one of the important areas of design and study. So it is good to take into consideration that, in this regard, there are undeniable diversities between the EU and the USA. While health (see cichon krakow) care in the US is a topic of privates and insurance economic concerns, in most states in the EU it is governmental. This difference changes the way medicines are seen by the public. Thus, US pharmacies sell a wide choice of medications with a graphic pattern that in the EU is usual of mostly nutritional supplements.

On the other hand, in the EU, where the advertising of drugs is much more severe, the tablet packaging tends to fave a more dull appearance, with nothing fancy and no suggestions. The justification for this difference in marketing communications is clear: the package’s destination in Europe are doctors, while in the most of the US, the target of the package is the patient.